Literature DB >> 3380797

The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus.

R J Arceci1, J M Croop, S B Horwitz, D Housman.   

Abstract

A survey of the expression of the multidrug-resistance gene (mdr) in mouse tissues revealed that a mdr mRNA species is expressed at extremely high levels in the gravid uterus. mdr mRNA expression levels increase dramatically during pregnancy compared to the relatively low levels of expression observed in the nongravid uterus. In situ hybridization experiments revealed that the increased expression of the mdr mRNA is specifically localized to the secretory epithelial cells of the endometrium. Immunocytochemistry studies with a mdr glycoprotein-specific antiserum demonstrate that the mdr glycoprotein is predominantly localized to the luminal surface of the secretory epithelial cells. These results indicate that the mdr gene expression in the uterus is controlled by the physiologic changes associated with pregnancy. Our data are consistent with a potential role for the mdr glycoprotein in the transport of substrate across the secretory epithelium of the gravid uterus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380797      PMCID: PMC280426          DOI: 10.1073/pnas.85.12.4350

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  The effect of protein fractions from rabbit uterine fluids on embryo growth and uptake of nucleic acid and protein precursors.

Authors:  A A el-Banna; J C Daniel
Journal:  Fertil Steril       Date:  1972-02       Impact factor: 7.329

Review 3.  Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.

Authors:  T Skovsgaard; K Danø; N I Nissen
Journal:  Cancer Treat Rev       Date:  1984-03       Impact factor: 12.111

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Detection of mrnas in sea urchin embryos by in situ hybridization using asymmetric RNA probes.

Authors:  K H Cox; D V DeLeon; L M Angerer; R C Angerer
Journal:  Dev Biol       Date:  1984-02       Impact factor: 3.582

6.  Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells.

Authors:  I B Roninson; H T Abelson; D E Housman; N Howell; A Varshavsky
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

7.  Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells.

Authors:  T Skovsgaard
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

8.  Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures.

Authors:  R C Strohman; P S Moss; J Micou-Eastwood; D Spector; A Przybyla; B Paterson
Journal:  Cell       Date:  1977-02       Impact factor: 41.582

9.  Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

Authors:  N Kartner; J R Riordan; V Ling
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

10.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

View more
  53 in total

1.  Multidrug resistance P-glycoprotein function of bone marrow hematopoietic cells and the reversal agent effect.

Authors:  Z Chen; A Takeshita; P Zou; Z Liu; M Kozaka; Y You; S Song; K Ohnishi; R Ohno
Journal:  J Tongji Med Univ       Date:  1999

Review 2.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  Cell-specific activity of cis-acting regulatory elements in the promoter of the mouse multidrug resistance gene mdr1.

Authors:  M Raymond; P Gros
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 4.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Isolation and characterization of Drosophila multidrug resistance gene homologs.

Authors:  C T Wu; M Budding; M S Griffin; J M Croop
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

6.  P-glycoprotein structure and evolutionary homologies.

Authors:  I Bosch; J M Croop
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 7.  Genetic basis of multidrug resistance of tumor cells.

Authors:  S E Kane; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1990-08       Impact factor: 2.945

8.  Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development.

Authors:  R J Arceci; F Shanahan; E R Stanley; J W Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  Cloning and regulation of the rat mdr2 gene.

Authors:  P C Brown; S S Thorgeirsson; J A Silverman
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

10.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.